Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer

被引：0
|
作者：
Ratosa, I. [1 ]
Scoccimarro, E. [2 ,3 ]
Dominici, L. [2 ,3 ]
Orazem, M. [1 ]
Steinacher, M. [4 ]
Aquilano, M. [2 ,3 ]
Cerbai, C. [2 ,3 ]
Desideri, I. [2 ,3 ]
Marinko, T. [1 ]
Livi, L. [2 ,3 ]
Meattini, I. [2 ,3 ]
机构：
[1] Inst Oncol, Div Radiat Oncol, Ljubljana, Slovenia
[2] Univ Florence, Dept Expt & Clin Biomed Sci M Serio, Florence, Italy
[3] Azienda Osped Univ Careggi, Radiat Oncol Unit, Dept Oncol, Florence, Italy
[4] Univ Med Ctr Maribor, Dept Oncol, Maribor, Slovenia
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
262
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2-Breast Cancer: A Systematic Review and Meta-Analysis
    Hong, Kai
    Yao, Lingli
    Sheng, Xianneng
    Ye, Dan
    Guo, Yu
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (10) : 557 - 567
  • [32] Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naive Metastatic Breast Cancer
    Finn, Richard S.
    Liu, Yuan
    Zhu, Zhou
    Martin, Miguel
    Rugo, Hope S.
    Dieras, Veronique
    Im, Seock-Ah
    Gelmon, Karen A.
    Harbeck, Nadia
    Lu, Dongrui R.
    Gauthier, Eric
    Bartlett, Cynthia Huang
    Slamon, Dennis J.
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 110 - 121
  • [33] Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysis
    Takatsuka, Daiki
    Sawaki, Masataka
    Hattori, Masaya
    Yoshimura, Akiyo
    Kotani, Haruru
    Kataoka, Ayumi
    Horisawa, Nanae
    Ozaki, Yuri
    Endo, Yuka
    Nozawa, Kazuki
    Iwata, Hiroji
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (05) : E175 - E182
  • [34] Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
    Spring, Laura M.
    Scarpetti, Lauren
    Medford, Arielle J.
    Niemierko, Andrzej
    Comander, Amy
    Mulvey, Therese
    Schnipper, Lowell
    Isakoff, Steven J.
    Moy, Beverly
    Wander, Seth A.
    Shin, Jennifer
    Ephrem, Zanta
    Laposta, Anneke R.
    Denault, Elyssa
    Abraham, Elizabeth
    Calistro, Gayle
    Kalashnikova, Ekaterina
    Rodriguez, Angel
    Liu, Minetta C.
    Aleshin, Alexey
    Peppercorn, Jeffrey
    Ellisen, Leif W.
    Bardia, Aditya
    NPJ BREAST CANCER, 2025, 11 (01)
  • [35] Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
    Graf, F.
    Mosch, B.
    Koehler, L.
    Bergmann, R.
    Wuest, F.
    Pietzsch, J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 527 - 539
  • [36] Combination of Cyclin-Dependent Kinase 4 Inhibitors and Androgen Receptor Inhibitors as Cancer Therapy
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (09): : 1408 - 1410
  • [37] Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer
    Kim, Kristine N.
    Shah, Payal
    Clark, Amy
    Freedman, Gary M.
    Dastgheyb, Sana
    Barsky, Andrew R.
    Dreyfuss, Alexandra D.
    Taunk, Neil K.
    BREAST, 2021, 60 : 163 - 167
  • [38] PET cell proliferation imaging biomarkers for monitoring drug action of combined cyclin-dependent kinase inhibitors and endocrine therapy in breast cancer
    Elmi, Azadeh
    MaKvandi, Mehran
    Weng, Chi-Chang
    Clark, Amy
    Mach, Robert
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [39] Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors
    Jeong, Hyehyun
    Ryu, Jeongryul
    Jeong, Jae Ho
    Han, Sangwon
    Hyung, Jaewon
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Jeong, Byung-Kwan
    Lee, Hee Jin
    Gong, Gyungyub
    Moon, Dae Hyuk
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 2096 - 2106
  • [40] Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
    Tadesse, Solomon
    Caldon, Elizabeth C.
    Tilley, Wayne
    Wang, Shudong
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4233 - 4251
12345